Accepted for Publication: October 1, 2019.
Published: November 22, 2019. doi:10.1001/jamanetworkopen.2019.16008
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2019 Li BY et al. JAMA Network Open.
Corresponding Author: Ted A. Skolarus, MD, MPH, Dow Division for Urologic Health Services Research, Department of Urology, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109 (tskolar@med.umich.edu).
Author Contributions: Dr Skolarus had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Li, Urish, Jacobs, Borza, Ellimoottil, Lavieri, Helm, Skolarus.
Acquisition, analysis, or interpretation of data: Li, Urish, Jacobs, He, Borza, Qin, Min, Dupree, Hollenbeck, Lavieri, Skolarus.
Drafting of the manuscript: Li, Urish, Min, Helm, Skolarus.
Critical revision of the manuscript for important intellectual content: Li, Urish, Jacobs, He, Borza, Qin, Dupree, Ellimoottil, Hollenbeck, Lavieri, Skolarus.
Statistical analysis: He, Qin, Min, Lavieri.
Obtained funding: Urish.
Administrative, technical, or material support: Urish, Dupree, Lavieri, Skolarus.
Supervision: Urish, Jacobs, Borza, Dupree, Lavieri, Helm, Skolarus.
Conflict of Interest Disclosures: Dr Urish reported receiving grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases during the conduct of the study, being a paid consultant with Smith and Nephew, and being a board member of the American Academy of Orthopedic Surgeons and ASTM International (formerly known as American Society for Testing and Materials). Dr Dupree reported receiving grants from Blue Cross Blue Shield of Michigan and owning personal, common stock in Lipocine outside the submitted work. Dr Hollenbeck reported receiving grants from the National Institute on Aging during the conduct of the study and being an Associate Editor of Urology. Dr Lavieri reported receiving grants from the National Science Foundation during the conduct of the study. No other disclosures were reported.
Funding/Support: Dr Urish is supported in part by the Institutional Career Development Award KL2TR0001856 from the National Institutes of Health and by a New Investigator Award from the Orthopaedic Research and Education Foundation. Dr Jacobs is supported in part by the Institutional Career Development Award KL2TR000146-08, a GEMSSTAR award (R03AG048091), and the Jahnigen Career Development Award, all from the National Institutes of Health. Dr Borza is supported by a Training Grant (T32-CA180984) from the National Cancer Institute. Dr Hollenbeck is supported by the Research Project Grant R01-AG-048071 from the National Institute on Aging. Dr Lavieri is supported by a Civil, Mechanical and Manufacturing Innovation Career Award (CMMI-1552545) from the National Science Foundation. Dr Skolarus is supported by a Health Services Research and Development Career Development Award (CDA 12-171) from the US Department of Veterans Affairs.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The research content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
5.Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2013 rates; hospitals’ resident caps for graduate medical education payment purposes; quality reporting requirements for specific providers and for ambulatory surgical centers: final rule.
Fed Regist. 2012;77(170):53257-53750.
PubMedGoogle Scholar 6.Centers for Medicare and Medicaid Services (CMS), HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2015 rates; quality reporting requirements for specific providers; reasonable compensation equivalents for physician services in excluded hospitals and certain teaching hospitals; provider administrative appeals and judicial review; enforcement provisions for organ transplant centers; and electronic health record (EHR) incentive program: final rule.
Fed Regist. 2012;79(163):49853-50536.
PubMedGoogle Scholar 7.Dartmouth Atlas of Health Care. Inpatient hip replacement per 1,000 Medicare enrollees, by gender.
http://archive.dartmouthatlas.org/data/table.aspx?ind=89&tf=34&ch=32&loc=2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52&loct=2&fmt=114. Accessed October 16, 2019.
10.Gilman
M, Adams
EK, Hockenberry
JM, Wilson
IB, Milstein
AS, Becker
ER. California safety-net hospitals likely to be penalized by ACA value, readmission, and meaningful-use programs.
Health Aff (Millwood). 2014;33(8):1314-1322. doi:
10.1377/hlthaff.2014.0138PubMedGoogle ScholarCrossref 12.Gilman
M, Hockenberry
JM, Adams
EK, Milstein
AS, Wilson
IB, Becker
ER. The financial effect of value-based purchasing and the hospital readmissions reduction program on safety-net hospitals in 2014: a cohort study.
Ann Intern Med. 2015;163(6):427-436. doi:
10.7326/M14-2813PubMedGoogle ScholarCrossref 13.Gu
Q, Koenig
L, Faerberg
J, Steinberg
CR, Vaz
C, Wheatley
MP. The Medicare Hospital Readmissions Reduction Program: potential unintended consequences for hospitals serving vulnerable populations.
Health Serv Res. 2014;49(3):818-837. doi:
10.1111/1475-6773.12150PubMedGoogle ScholarCrossref 16.Halawi
MJ, Greene
K, Barsoum
WK. Optimizing outcomes of total joint arthroplasty under the comprehensive care for joint replacement model.
Am J Orthop (Belle Mead NJ). 2016;45(3):E112-E113.
PubMedGoogle Scholar 18.Bozic
KJ, Maselli
J, Pekow
PS, Lindenauer
PK, Vail
TP, Auerbach
AD. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery.
J Bone Joint Surg Am. 2010;92(16):2643-2652. doi:
10.2106/JBJS.I.01477PubMedGoogle ScholarCrossref 19.Paxton
EW, Inacio
MC, Singh
JA, Love
R, Bini
SA, Namba
RS. Are there modifiable risk factors for hospital readmission after total hip arthroplasty in a US healthcare system?
Clin Orthop Relat Res. 2015;473(11):3446-3455. doi:
10.1007/s11999-015-4278-xPubMedGoogle ScholarCrossref 22.Davies
JM, Lawton
MT. Improved outcomes for patients with cerebrovascular malformations at high-volume centers: the impact of surgeon and hospital volume in the United States, 2000-2009.
J Neurosurg. 2017;127(1):69-80. doi:
10.3171/2016.7.JNS15925PubMedGoogle ScholarCrossref 27.Rajaram
R, Chung
JW, Kinnier
CV,
et al. Hospital characteristics associated with penalties in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program.
JAMA. 2015;314(4):375-383. doi:
10.1001/jama.2015.8609PubMedGoogle ScholarCrossref 39.Vorhies
JS, Wang
Y, Herndon
JH, Maloney
WJ, Huddleston
JI. Decreased length of stay after TKA is not associated with increased readmission rates in a national Medicare sample.
Clin Orthop Relat Res. 2012;470(1):166-171. doi:
10.1007/s11999-011-1957-0PubMedGoogle ScholarCrossref 40.Sibley
RA, Charubhumi
V, Hutzler
LH, Paoli
AR, Bosco
JA. Joint replacement volume positively correlates with improved hospital performance on Centers for Medicare and Medicaid Services quality metrics.
J Arthroplasty. 2017;32(5):1409-1413. doi:
10.1016/j.arth.2016.12.010PubMedGoogle ScholarCrossref